Abstract
Background
The profile of patients with HIV/AIDS is required to develop appropriate HIV/AIDS prevention and treatment programs in Indonesia. Turen is one of the four sub-districts with the highest number of patients with HIV/AIDS in Malang District, Indonesia. The purpose of this study is to determine the sociodemographic profile, sources of infection, use of antiretrovirals and CD4 counts on HIV/AIDS outpatients in Turen Primary Health Centre (PHC).
Methods
The sociodemographic data, antiretroviral use, and CD4 counts were obtained from medical records on HIV/AIDS outpatients in Turen PHC. A qualitative approach using in-depth interviews was used to explore the source of infection. Descriptive analysis was used to summarise the quantitative data, while thematic analysis was used to analyse the qualitative data derived from interviews.
Results
A total of 45 HIV/AIDS outpatient medical records were reviewed. Of those, the majority were females (57.8%), ages 26–35 years (51.1%), married (55.6%) and having income less than 2 million rupiah (73.3%). All of them used a combination of antiretroviral therapy from two classes of antiretrovirals, i.e. nucleotide analog reverse transcriptase inhibitor and non-nucleotide analog reverse transcriptase inhibitor; the majority were treated with fixed-dose combination of tenofovir-lamifudin-efavirenz. The CD4 counts data were obtained from 31 patients with an average number of 282 cells/mm3. The qualitative data from interviews with 15 patients revealed that the source of infection was from husband, unsafe/unprotected sex and blood donor.
Conclusions
The high prevalence of HIV/AIDS among young married women and poor control of the disease in Indonesia warrants further considerations. The government should work together with all related stakeholders in raising awareness of HIV/AIDS, particularly among women, as well as improving treatment and support for people living with HIV/AIDS.
Acknowledgment
We thank all the participants who took part in this study as well as the chief and staff from Turen Primary Health Centre, for their technical support in making this study possible.
Research funding: None declared.
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
Competing interests: Authors state no conflict of interest.
Informed consent: Informed consent was obtained from all individuals included in this study.
Ethical approval: This study has received ethics approval from the Institutional Ethical Committee of the University of Surabaya (number 041/KE/X/2018) and obtained permission from the Malang District Health Office (number 072/3385/35.07.103/2018) in which respondents’ confidentiality were guaranteed on any published data.
References
[1] The Ministry of Health of the Republic of Indonesia. The National Guidelines for Clinical Management of HIV Infection and Antiretroviral Therapy in Adult. 2011:1–121.Search in Google Scholar
[2] Alldredge BK, Affairs A, Francisco S, Francisco S, Corelli RL, Francisco S, et al. Applied therapeutics the clinical use of drugs. Tenth. Philadelphia: Lippincott Williams & Wilkins, 2013:1717–26.Search in Google Scholar
[3] Molino CG, Cavalcanti R, Teotonio A, Moriel P, Gava P. HIV pharmaceutical care in primary healthcare: improvement in CD4 count and reduction in drug-related problems. Saudi Pharm J 2017;25:724–33.10.1016/j.jsps.2016.11.004Search in Google Scholar PubMed PubMed Central
[4] Badri M, Lawn SD, Wood R. Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting. BMC Infect Dis 2008;8:1–8.10.1186/1471-2334-8-89Search in Google Scholar PubMed PubMed Central
[5] Buehler K, Spencer-Rodgers J, Peng K. HIV/AIDS, treatment adherence, and lifestyle: a qualitative study. J HIV AIDS Soc Serv 2017;16:1–15.10.1080/15381501.2017.1328326Search in Google Scholar
[6] Buzon MJ, Martin-gayo E, Pereyra F, Ouyang Z, Sun H, Li JZ, et al. Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells. J Virol 2014;88:10056–65.10.1128/JVI.01046-14Search in Google Scholar PubMed PubMed Central
[7] The Ministry of Health of the Republic of Indonesia. Regulation of the Minister of Health of the Republic of Indonesia Number 87 Year 2014 on Guidelines for Antiretroviral Treatment. 2014:1–121.Search in Google Scholar
[8] The Ministry of Health of the Republic of Indonesia DITJEN P2P 2017. Progress Progress Progress Progress Reports Progress Reports of HIV/AIDS and Sexually Transmitted Infections Quarterly 1 2017;1400.Search in Google Scholar
[9] Data and Information Center Repubik Indonesian Health Ministry. Situation and Analysis of HIV/AIDS. 2014;1–8.Search in Google Scholar
[10] Sembiring EP, Haryono BS, Sukanto. Implementation of Perda No. 14 Year 2008 on combating HIV and AIDS in Malang (study of the role of communication in public policy implementation). J Adm Publik 2008;1:183–91.Search in Google Scholar
[11] Shukla Y, Rohit BK, Tiwari R, Kasar PK. Sociodemographic profile of people living with HIV/AIDS attending ART center in a tertiary-care hospital in central India. Int J Med Sci Public Health 2015;4:10–3.10.5455/ijmsph.2015.20062015301Search in Google Scholar
[12] Hutapea HM, Mirino Y, Widiyanti M, Fitriana E, Maladan Y, Oktavian A. Decreased CD4 in those therapy Arv after more than 39 months. Media Kesehat Mobi Indones 2017;13:267.10.30597/mkmi.v13i3.1048Search in Google Scholar
[13] Murray LK, Semrau K, McCurley E, Thea DM, Scott N, Mwiya M, et al. Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care 2010;21:1–14.10.1080/09540120802032643Search in Google Scholar PubMed PubMed Central
[14] Hidayati NR, Abdillah S, Keban SA. Analysis of adverse drug reactions of anti retroviral drugs in patients treatment of HIV/AIDS in Gunung Jati Hospital in Cirebon 2013. Pharmaciana 2016;6:79–88.10.12928/pharmaciana.v6i1.3327Search in Google Scholar
[15] Smith K, Riche D, Henyan N. Clinical drug data, 11th ed. 2 Penn Plaza, 23rd Floor New York, NY: McGraw-Hill Companies, 2010:2124.10.1093/ajhp/67.24.2124Search in Google Scholar
[16] Chesney MA, Ickovics JR, Chambers DB. Psychological and socio-medical aspects of AIDS/HIV self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. AIDS Care 2010;12:37–41.10.1080/09540120050042891Search in Google Scholar
[17] Sabate E, Chesney MA, Farmer PL, Leandre F, Malow R, Stearace F. Adherence to long-term therapies. Switzerland. Marketing and Dissemination World Health Organization. 2003;1–211 .Search in Google Scholar
[18] Crowley S, Vitoria M. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach 2010 revision. Switzerland: WHO Press World Health Organization, 2010:1–156.Search in Google Scholar
[19] Smith CJ, Sabin CA, Youle MS, Loes SK, Lampe FC, Madge S, et al. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy. J Infect Diseasses 2004;190:1860–8.10.1086/425075Search in Google Scholar PubMed
[20] Segeral O, Madec Y, Ban B, Ouk V, Hak CR, Le Tiec C, et al. Simplified assessment of antiretroviral adherence and prediction of virological efficacy in HIV-infected patients in Cambodia. AIDS Res Treat 2010;2010:1–7.10.1155/2010/142076Search in Google Scholar PubMed PubMed Central
[21] Nasronudin , Barakbah J, Soewandojo E, Suharto , Hadi U. HIV and AIDS approach molecular biology, clinical and social affair. 1st ed. Surabaya: Airlangga University Press, 2007.Search in Google Scholar
[22] Thompson MA, Mugavero MJ, Amico KR, Cargill VA. Annals of internal medicine clinical guideline guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an international association of physicians in AIDS care panel. Ann Intern Med 2012;156:817–33.10.7326/0003-4819-156-11-201206050-00419Search in Google Scholar PubMed PubMed Central
[23] Casado JL, Collazos J, Knobel H, Alonso J, Ruiz I, Kindelan JM, et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA study. AIDS 2002;16:605–13.10.1097/00002030-200203080-00012Search in Google Scholar PubMed
[24] The Ministry of Health of the Republic of Indonesia. Regulation of the Minister of Health of the Republic of Indonesia Number 87 Year 2014 on Guidelines for antiretroviral treatment. Jakarta: Indonesia State Gazette, number 72 in 2015;2014:1–121.Search in Google Scholar
[25] Cummins NW, Sainski AM, Natesampillai S, Bren GD, Badley AD. Choice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cells. Mol Cell Ther 2014;2:1–7.10.1186/2052-8426-2-1Search in Google Scholar PubMed PubMed Central
[26] Rosamond E, Weaver N, Pane M, Wandra T, Windiyaningsih C. Factors that influence adherence to antiretroviral treatment in an urban population, Jakarta, Indonesia. PLoS One 2014;9:1–7.10.1371/journal.pone.0107543Search in Google Scholar
[27] Yuniar Y, Handayani RS ANK. Factors – factors compliance support people living with HIV AIDS (PLWHA) antiretroviral drugs in drinking in Bandung and Cimahi. Health Res Bull 2013:72–83.Search in Google Scholar
[28] Roselinda R, Wibowo HA, Setiawaty V. Karakteristik Pekerjaan pada Kasus Human Immunodeficiency Virus-1 dan Subtipenya di Tujuh Provinsi di Indonesia pada tahun 2011. Medisiana Indonesia 2015;4(2):71–6.10.22435/jbmi.v4i2.5127.71-76Search in Google Scholar
[29] Sabin LL, Barriers to adherence to antiretroviral medications among patients living with HIV in southern China: a qualitative study. AIDS Care. 2008;20(10):1242–50.10.1080/09540120801918651Search in Google Scholar PubMed PubMed Central
[30] Khan MA, Shasi S. Socio-demographic and clinical profile of people living with HIV/AIDS. Asian J Med Sci. 2012;3(2):1–10.10.3126/ajms.v3i2.5039Search in Google Scholar
© 2019 Walter de Gruyter GmbH, Berlin/Boston
